Crucial Gut Bacteria in Infants Linked to Higher Risk of Asthma, Eczema, and Allergies by Age Two

Spread the Message

Read Time:4 Minute, 30 Second

Without these crucial gut bacteria, babies face a higher risk of asthma, eczema, and allergies by age 2, a new large study reveals. Researchers found that many infants in the United States lack essential Bifidobacterium microbes, which digest breast milk and help train the developing immune system during early life—a critical window for long-term health.

Essential Gut Microbes Missing in Many Babies

A study involving 412 infants across 48 U.S. states found that about 25% of babies had no detectable Bifidobacterium in their gut, with only 8% showing the presence of Bifidobacterium infantis, a particularly beneficial species. Overall, 76% had low or undetectable levels of Bifidobacterium, and these babies were at least three times more likely to develop allergic conditions such as asthma, eczema, and food allergies by their second birthday.

Stephanie Culler, co-author and scientist at Persephone Biosciences, a San Diego biotech company that led the study, described the findings as surprising and concerning given the fundamental role of this bacterial family in infant health .

Why Bifidobacterium Matters for the Infant Immune System

Bifidobacteria are among the earliest colonizers of the infant gut, playing a key role in shaping the microbial community through what is known as “priority effects”—the idea that the first microbes to establish influence which species follow. These bacteria are uniquely adapted to consume human milk oligosaccharides (HMOs), complex sugars found in breast milk.

By breaking down HMOs, Bifidobacterium produces metabolic byproducts like acetate and lactate that lower the gut pH. This acidic environment discourages the growth of harmful pathogens and supports beneficial microbes. Moreover, these bacteria contribute to vitamin production and generate chemical signals essential for guiding the infant’s developing immune system. These signals help the immune system respond appropriately to environmental and dietary exposures, potentially reducing allergic sensitization .

Influence of Birth Mode, Feeding, and Antibiotics

The study showed that an infant’s mode of delivery and feeding practices significantly impact microbial colonization. Babies born vaginally tend to have higher levels of Bifidobacterium, especially when breastfed. In contrast, many babies born via Cesarean section displayed low levels of these beneficial bacteria, even when breastfed, because other microbes competed for the same milk sugar niche without providing the same immune benefits.

Importantly, the use of antibiotics during the first two years of life correlated with a 3.3-fold increase in allergic diseases, compared to children who were not given antibiotics. Antibiotics can disrupt the timely establishment of these critical gut microbes, allowing other potentially harmful bacteria with antimicrobial resistance and virulence genes to thrive, altering the gut environment in ways that may increase susceptibility to allergies .

Broader Lifestyle and Public Health Implications

Modern lifestyle factors such as increased industrial food processing, widespread use of antibacterial products, and reduced microbial exposures within families and communities likely contribute to the decline of Bifidobacterium colonization in infants. This shift could partly explain rising rates of asthma, eczema, and allergies in children.

Preventing the loss of these cornerstone microbes highlights the importance of supporting natural birth practices when possible, promoting breastfeeding, and exercising cautious antibiotic use during early childhood. Such measures could help maintain a beneficial gut microbial environment, influencing immune development in a way that reduces allergy risk .

Cautions and Continuing Research

While the association between low Bifidobacterium levels and increased allergic disease risk is robust in this cohort, direct causation has yet to be definitively proven. The research team plans to follow the children for seven years to see which gut microbiome patterns persist and how often natural microbial recovery occurs.

Interest in probiotic supplements for infants is growing, but experts urge caution. In 2023, the U.S. Food and Drug Administration (FDA) issued a safety advisory against giving probiotics to hospitalized preterm infants due to rare cases of sepsis linked to such products. However, this advisory does not apply to healthy term infants outside hospital environments, where ongoing research is still defining the role and safety of probiotics .

Expert Perspectives

Dr. Anne Smith, a pediatric immunologist not involved in the study, explains, “This research underscores the critical importance of the infant gut microbiome in training the immune system. Protecting and restoring beneficial bacteria like Bifidobacterium may be key in reducing the burden of allergic diseases, which have been increasing globally.”

What This Means for Parents and Caregivers

For parents and caregivers, these findings emphasize the value of breastfeeding when possible, as breast milk contains vital HMOs that nurture beneficial gut bacteria. Avoiding unnecessary antibiotic use in early childhood could also support healthy microbial colonization. While probiotic supplements are an area of active study, parents should consult with pediatricians to determine the best approach for their infant’s unique health needs.

Conclusion

This extensive study highlights the vital role of Bifidobacterium in early life immune development and its strong link to allergy risk by age two. Efforts to safeguard infant microbial health through feeding practices, birth methods, and judicious antibiotic use could become a cornerstone of strategies aimed at reducing childhood allergic diseases.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.